We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.

Search Results

Showing 1-20 of 2,700 results
  1. Integrative rare disease biomedical profile based network supporting drug repurposing or repositioning, a case study of glioblastoma

    Background

    Glioblastoma (GBM) is the most aggressive and common malignant primary brain tumor; however, treatment remains a significant challenge....

    Erin McGowan, Jaleal Sanjak, ... Qian Zhu in Orphanet Journal of Rare Diseases
    Article Open access 25 September 2023
  2. Comprehensive review of the repositioning of non-oncologic drugs for cancer immunotherapy

    Drug repositioning or repurposing has gained worldwide attention as a plausible way to search for novel molecules for the treatment of particular...

    Abdur Rauf, Payal B. Joshi, ... Rekha Thiruvengadam in Medical Oncology
    Article 23 April 2024
  3. Enriching limited information on rare diseases from heterogeneous networks for drug repositioning

    Background

    The historical data of rare disease is very scarce in reality, so how to perform drug repositioning for the rare disease is a great...

    Hongkui Cao, Liang Zhang, ... Chao Che in BMC Medical Informatics and Decision Making
    Article Open access 16 November 2021
  4. Drug Repurposing for Emerging Infectious Diseases and Cancer

    ​This book presents drug repurposing strategies to combat infectious diseases and cancer. It discusses key experimental and in silicoapproaches for...

    Ranbir Chander Sobti, Sunil K. Lal, Ramesh K. Goyal
    Book 2023
  5. A polo-like kinase inhibitor identified by computational repositioning attenuates pulmonary fibrosis

    Background

    Idiopathic pulmonary fibrosis (IPF) is a fatal fibrotic lung disease with few effective therapeutic options. Recently, drug repositioning,...

    Takeshi Imakura, Seidai Sato, ... Yasuhiko Nishioka in Respiratory Research
    Article Open access 02 June 2023
  6. Repositioning synthetic glucocorticoids in psychiatric disease associated with neural autoantibodies: a narrative review

    Synthetic glucocorticoids (sGCs) are a well-investigated and standard drug therapy for disorders associated with CNS inflammation. Less is known...

    Niels Hansen, Alexandra Neyazi, ... Berend Malchow in Journal of Neural Transmission
    Article Open access 28 December 2022
  7. The effects of exercise training on knee repositioning sense in people with knee osteoarthritis: a systematic review and meta-analysis of clinical trials

    Objective

    Osteoarthritis (OA) of the knee is one of the most common global joint disorders, especially in aging population, and is among leading...

    Rahman Sheikhhoseini, Mahdis Dadfar, ... Mohammad Salsali in BMC Musculoskeletal Disorders
    Article Open access 19 July 2023
  8. An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19

    The global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) requires an urgent need to find effective therapeutics for the...

    Yiyue Ge, Tingzhong Tian, ... Jianyang Zeng in Signal Transduction and Targeted Therapy
    Article Open access 24 April 2021
  9. Drug repositioning and repurposing for Alzheimer disease

    Drug repositioning and repurposing can enhance traditional drug development efforts and could accelerate the identification of new treatments for...

    Clive Ballard, Dag Aarsland, ... Janet Sultana in Nature Reviews Neurology
    Article 16 September 2020
  10. Integrated systems biology analysis of acute lymphoblastic leukemia: unveiling molecular signatures and drug repurposing opportunities

    Acute lymphoblastic leukemia (ALL) is a hematological malignancy characterized by aberrant proliferation and accumulation of lymphoid precursor cells...

    Betül Budak, Ezgi Yağmur Tükel, ... Yağmur Kiraz in Annals of Hematology
    Article Open access 05 June 2024
  11. A computational multi-targeting approach for drug repositioning for psoriasis treatment

    Background

    Psoriasis is an autoimmune inflammatory skin disease that affects 0.5–3% of the world’s population and current treatment options are posed...

    Akachukwu Ibezim, Emmanuel Onah, ... Fidele Ntie-Kang in BMC Complementary Medicine and Therapies
    Article Open access 05 July 2021
  12. Drug-repositioning screening identified fludarabine and risedronic acid as potential therapeutic compounds for malignant pleural mesothelioma

    Objectives Malignant pleural mesothelioma (MPM) is an occupational disease mainly due to asbestos exposure. Effective therapies for MPM are lacking,...

    Irene Dell’Anno, Sarah A. Martin, ... Stefano Landi in Investigational New Drugs
    Article Open access 09 December 2020
  13. Drug repositioning for psychiatric and neurological disorders through a network medicine approach

    Psychiatric and neurological disorders (PNDs) affect millions worldwide and only a few drugs achieve complete therapeutic success in the treatment of...

    Thomaz Lüscher Dias, Viviane Schuch, ... Helder Imoto Nakaya in Translational Psychiatry
    Article Open access 12 May 2020
  14. Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

    Drug resistance represents a major obstacle in cancer management, and the mechanisms underlying stress adaptation of cancer cells in response to...

    ** **, **gwen Jiang, ... Li Fu in Journal of Hematology & Oncology
    Article Open access 18 July 2022
  15. Analysis and identification of drug similarity through drug side effects and indications data

    Background

    The measurement of drug similarity has many potential applications for assessing drug therapy similarity, patient similarity, and the...

    Amir Torab-Miandoab, Mehdi Poursheikh Asghari, ... Reza Ferdousi in BMC Medical Informatics and Decision Making
    Article Open access 14 February 2023
  16. Using the drug repositioning approach to develop a novel therapy, tipepidine hibenzate sustained-release tablet (TS-141), for children and adolescents with attention-deficit/hyperactivity disorder

    Background

    Asverin® (tipepidine hibenzate) has been used as an antitussive for > 50 years in Japan. Studies revealed that tipepidine modulates...

    Takuya Saito, Yushiro Yamashita, ... Kazuhiko Saito in BMC Psychiatry
    Article Open access 10 November 2020
  17. Exploration of key drug target proteins highlighting their related regulatory molecules, functional pathways and drug candidates associated with delirium: evidence from meta-data analyses

    Background

    Delirium is a prevalent neuropsychiatric medical phenomenon that causes serious emergency outcomes, including mortality and morbidity. It...

    Md Parvez Mosharaf, Khorshed Alam, ... Rashidul Alam Mahumud in BMC Geriatrics
    Article Open access 22 November 2023
  18. A drug-repositioning screen using splicing-sensitive fluorescent reporters identifies novel modulators of VEGF-A splicing with anti-angiogenic properties

    Alternative splicing of the vascular endothelial growth factor A ( VEGF-A ) terminal exon generates two protein families with differing functions....

    Eleanor Star, Megan Stevens, ... Sebastian Oltean in Oncogenesis
    Article Open access 03 May 2021
Did you find what you were looking for? Share feedback.